Search
for
Sort by
Research 301–330 of 874
- Polycystic ovary syndrome
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Common Baldness in Women
- An updated review of the sebaceous gland and its role in health and diseases Part 2: Pathophysiological clinical disorders of sebaceous glands
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial
- Chapter 23. Therapeutic Control of Androgen Action
- Prenatal Androgenization of Ewes as a Model of Hirsutism in Polycystic Ovary Syndrome
- UPDATE ON IDIOPATHIC HIRSUTISM: DIAGNOSIS AND TREATMENT
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Heterogeneity of Polymorphous Light Eruption: A Study of 105 Patients
- Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation
- Endocrine disorders and hormonal therapy for adolescent acne
- Endocrine evaluation of hirsutism
- Epidemiology and Management of Acne in Adult Women
- PCOS: Perspectives from a Pediatric Endocrinologist and a Pediatric Gynecologist
- Recent therapeutic developments for acne
- Polycystic ovary syndrome: Challenges in adolescence
- Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS—A prospective study
- Acne
- Secondary amenorrhea
- An update on diagnosis and treatment of female pattern hair loss
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Healthy Skin for Women: A Review of Common Conditions and Therapies
- Alopecia due to high androgen index contraceptives
- Serum ferritin levels in non-scarring alopecia of women: a case-control study
- Women’s Health Considerations for Lipid Management
- Steroid Hormones
- Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
- Clinical use of 5α-reductase inhibitors